Title : Assessment of HER2 status in patients with gastroesophageal adenocarcinoma treated with epirubicin-based chemotherapy: heterogeneity-related issues and prognostic implications.

Pub. Date : 2017 May

PMID : 27530622






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Assessment of HER2 status in patients with gastroesophageal adenocarcinoma treated with epirubicin-based chemotherapy: heterogeneity-related issues and prognostic implications. Epirubicin erb-b2 receptor tyrosine kinase 2 Homo sapiens
2 CONCLUSIONS: HER2 status is an independent prognostic biomarker in gastroesophageal adenocarcinomas receiving epirubicin-based chemotherapy. Epirubicin erb-b2 receptor tyrosine kinase 2 Homo sapiens